Study reveals how PRC2 guides preimplantation development and primordial germ cell fate

A new study has revealed that the epigenetic regulator PRC2 performs different, stage-specific jobs during the earliest phases of mammalian embryonic development. The findings, reported by Zhou, Wang, Chen and colleagues in Nature Cell Biology, show that PRC2 is not simply a molecular “off switch” that silences genes. Instead, it helps coordinate the maternal-to-zygotic transition, supports the emergence of the epiblast, controls the timing of epigenetic states known as bivalency and indirectly determines how many primordial germ cells are produced. The work provides a detailed view of how chromatin regulation can influence communication between embryonic and extraembryonic tissues, linking events inside individual cells to developmental decisions made across the early embryo.

PRC2, or Polycomb repressive complex 2, is best known for placing the histone modification H3K27me3 on chromatin. Histones are proteins around which DNA is wrapped, and chemical marks on these proteins help regulate whether genes remain accessible for transcription. H3K27me3 is generally associated with gene repression, although its effects depend on developmental context and the presence of other regulatory signals. During embryogenesis, the genome is extensively reorganized after fertilization. Maternal messenger RNAs and proteins initially control development, but the embryo must soon activate its own genome. This handover, called the maternal-to-zygotic transition, requires precise changes in chromatin structure and gene activity. The new study shows that PRC2 is an important part of this transition rather than a passive regulator acting later in development.

The researchers used the dTAG system to remove PRC2 components rapidly and selectively at defined developmental stages. This approach differs from conventional genetic knockout experiments, which eliminate a gene throughout development and can make it difficult to determine when a protein is actually required. In the dTAG system, a small chemical molecule targets a tagged protein for destruction, allowing investigators to examine the consequences of acute depletion at particular time points. By applying this strategy during preimplantation development, the team could distinguish PRC2 functions in the fertilized egg, early cleavage-stage embryos and the blastocyst from functions that emerge later. The results revealed that the complex has distinct requirements across these stages, indicating that its role changes as embryonic cell states become progressively specialized.

During preimplantation development, the embryo passes through a series of divisions before forming the blastocyst, a structure containing the future embryonic cells, the trophectoderm and the primitive endoderm. The study found that PRC2 contributes to the maternal-to-zygotic transition and to the formation of the epiblast, the cell population that will generate the embryo proper. When PRC2 activity was disrupted at inappropriate times, embryos showed defects in developmental progression and in the establishment of the epiblast. These observations suggest that PRC2 helps prevent premature or misplaced gene-expression programs while allowing the correct developmental network to emerge. Its activity therefore appears to provide temporal control: genes must be silenced at the right moment, but the chromatin landscape must also remain capable of being remodeled as cells acquire new identities.

A major focus of the work was the relationship between H3K27me3 and H3K4me3. H3K4me3 is commonly associated with gene activation and is enriched near promoters of actively transcribed genes. When H3K27me3 and H3K4me3 occur together at the same regulatory region, the chromatin is described as bivalent. Bivalent domains have traditionally been viewed as “poised” regulatory regions, carrying both repressive and activating signals so that developmental genes can respond rapidly when a cell commits to a new fate. However, the precise timing of bivalency formation in early embryos has remained uncertain, partly because embryonic chromatin changes rapidly and because different studies have used different definitions of a bivalent domain.

By systematically tracking both histone modifications, the researchers propose a revised model for when bivalency is established. Rather than appearing as a fully formed state at a single developmental moment, bivalency emerges through a stepwise process. One modification can be detected before the other, and the two marks become combined as development proceeds and cellular identities sharpen. This sequence challenges the idea that bivalent chromatin is installed in one coordinated event. It instead suggests that early embryonic cells build regulatory competence gradually, integrating repressive and active information over time. PRC2 is central to this process because it supplies the H3K27me3 component, while the distribution of H3K4me3 reflects the changing transcriptional and chromatin environment around developmental genes.

The study also identifies an unexpected connection between PRC2 activity outside the embryo proper and the production of primordial germ cells, or PGCs. PGCs are the embryonic precursors of sperm and eggs, and their numbers must be tightly controlled: too few can compromise reproductive potential, while abnormal expansion may disrupt tissue organization and developmental balance. The researchers found that PRC2 regulates appropriate PGC numbers in the epiblast through its control of Esrrb expression in the extraembryonic ectoderm. The extraembryonic ectoderm does not become part of the fetus, but it produces signals that influence neighboring embryonic cells. This places PRC2 within a non-cell-autonomous pathway, in which an epigenetic event in one tissue changes the behavior of cells in another.

The role of Esrrb helps explain how this intercellular effect is transmitted. Esrrb encodes a transcription factor, a protein that binds DNA and regulates suites of genes involved in cell identity and development. According to the study, changes in PRC2-dependent regulation of Esrrb in the extraembryonic ectoderm alter the developmental environment experienced by epiblast cells and consequently affect PGC formation. The finding illustrates that epigenetic regulation does not operate solely within the boundaries of a single cell. A chromatin complex can modify gene expression in one embryonic compartment, which then changes signals or conditions that guide fate decisions elsewhere. This epigenetic-to-transcription-factor-to-cell-communication pathway adds another layer to the already complex regulation of germline specification.

Taken together, the findings expand the biological definition of PRC2 during early embryogenesis. The complex acts cell-autonomously to organize chromatin and support preimplantation development, yet it also has broader developmental consequences through interactions between embryonic and extraembryonic tissues. The researchers’ results emphasize that the same epigenetic regulator can have different effects depending on developmental stage, cellular location and the surrounding transcriptional network. They also show why acute protein-depletion tools such as dTAG can be valuable for developmental biology: timing is often as important as molecular identity. By connecting histone-mark dynamics, transcription-factor control and intercellular signaling, the study offers a framework for understanding how embryos convert rapidly changing epigenetic information into coordinated developmental outcomes.